New and Revised FDA Import Alerts for March 4
On March 4 the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
- 99-43: Ready-to-Eat Human (RTE) Food Products that appear to Have Been Prepared, Packed or Held Under Insanitary Conditions (here)
- 99-33: Products from Japan due to Radionuclide Contamination (here)
- 99-32: Products from Firms Refusing FDA Foreign Establishment Inspection (here)
- 99-19: Food Products due to the Presence of Salmonella (here)
- 99-05: Raw Agricultural Products for Pesticides (here)
- 66-78: Drugs, Based Upon Analytic Test Results (here)
- 66-57: Foreign Manufactured Unapproved Prescription Drugs Promoted to Individuals in the U.S. (here)
- 66-41: Unapproved New Drugs Promoted in the U.S. (here)
- 24-23: Fresh Cilantro From the State of Puebla, Mexico -- Seasonal (April 1-Aug. 30) (here)
- 16-129: Seafood Products due to Nitrofurans (here)
- 16-81: Seafood Products due to the Presence of Salmonella (here)
- 16-39: Seafood and Analogue Seafood (Surimi) Products for Listeria Monocytogenes (here).